Fungal Endocarditis: Evidence in the World Literature, 1965-1995
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
We analyzed 270 cases of fungal endocarditis (FE) that occurred over 30 years. Vascular lines, non-cardiac surgery, immunocompromise and injection drug abuse are increasing risk factors. Delayed or mistaken diagnosis (82% of patients), long duration of symptoms before hospitalization (mean +/- standard deviation, 32+/-39 days) and extracardiac manifestations were characteristic. From 1988 onwards, 72% of patients were diagnosed preoperatively, compared with 43% before 1988 (P=.0001). The fungi most commonly isolated were Candida albicans (24% of patients), non-albicans species of Candida (24%), Apergillus species (24%), and Histoplasma species (6%); recently-emerged fungi accounted for 25% of cases. The mortality rate was 72%. Survival rates were better among patients who received combined surgical-antifungal treatment, were infected with Candida, and had univalvular involvement. Improvement in the survival rate (from <20% before 1974 to 41% currently) coincided with the introduction of echocardiography and with improved diagnostic acumen. Fungal endocarditis recurs in 30% of survivors. It is recommended that fungal endocarditis be diagnosed early through heightened diagnostic acumen; that patients be treated with combined lipid-based amphotericin B and early surgery; and that patients be followed up for > or =4 years while on prophylactic antifungal therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Blood cultures are ultimately positive in most cases caused by the former pathogen, whereas they are rarely positive in cases caused by the latter fungus.”
In the citing paper
“Fungal IE is rare but can develop in a wide range of patients.240,241”
In the citing paper
“Candida and Aspergillus species account for the large majority of fungal IE, and Candida-related IE is much more common than Aspergillus-related disease.240,241”
In the citing paper
“The well-recognized risk factors associated with fungal IE (eg, IDU and immunocompromised state) have become less prevalent compared with the presence of a cardiovascular device, including central venous catheters, permanent pacemakers and defibrillators, and prosthetic valves.[240][241][242][243][244][245][246]”
Citations
Cites
The Journal of Laboratory and Clinical Medicine
(2003) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(03)00127-6 · Cited by 1,767
The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species
Abi‐Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H., & Vartivarian, S. (1997) · Clinical Infectious Diseases · doi:10.1086/513663 · Cited by 755 · cited 1×
“albicans species over the years is consistent with the reported emergence of non-albicans species of Candida as a significant fungal pathogen in other settings [23, 24].”
ResultBiofilm formation by Candida species on the surface of catheter materials in vitro
Hawser, S. P., & Douglas, L. J. (1994) · Infection and Immunity · doi:10.1128/iai.62.3.915-921.1994 · Cited by 599 · cited 1×
“Histological examination has revealed lesions of established FE comprising large vegetations that have protective biofilms [25, 26], which raises concern about whether antifungal drugs can be effectively delivered, and hence doubt about the efficacy of antifungal treatment alone.”
BackgroundFungal infections in cancer patients: An international autopsy survey
Bodey, G., Bueltmann, B., Duguid, W., Gibbs, D., Hanak, H., Hotchi, M., Mall, G., Martino, P., Meunier, F., Milliken, S., et al. (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967060 · Cited by 547
Nosocomial Candidiasis: Emerging Species, Reservoirs, and Modes of Transmission
Pfaller, M. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s89 · Cited by 502
FUNGAL ENDOCARDITIS: ANALYSIS OF 24 CASES AND REVIEW OF THE LITERATURE
EUBINSTE1N, E., NOKIEGA, E. R., SIMBEEKOFF, M. S., HOLZMAN, E., & RAHAL, J. J. (1975) · Medicine · doi:10.1097/00005792-197507000-00003 · Cited by 275
RISK FACTORS FOR INFECTIVE ENDOCARDITIS
Steckelberg, J. M., & Wilson, W. R. (1993) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30502-x · Cited by 212
Rinaldi, M. G. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.6.1061 · Cited by 200
Girmenia, C., Martino, P., De Bernardis, F., Gentile, G., Boccanera, M., Monaco, M., Antonucci, G., & Cassone, A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.506 · Cited by 164
Aspergillus species endocarditis
Kammer, R. B., & Utz, J. P. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90483-5 · Cited by 146
FUNGAL ENDOCARDITIS: REVIEW OF THE LITERATURE AND REPORT OF THREE CASES
Merchant, R. K., Louria, D. B., GEISLER, P. H., Edgcomb, J. H., & Utz, J. P. (1958) · Annals of Internal Medicine · doi:10.7326/0003-4819-48-2-242 · Cited by 133
Endocarditis in the drug addict
Ramsey, R. G., Gunnar, R. M., & Tobin, J. R. (1970) · The American Journal of Cardiology · doi:10.1016/0002-9149(70)90600-4 · Cited by 116
Adherence of Candida albicans to a fibrin-platelet matrix formed in vitro
Maisch, P. A., & Calderone, R. (1980) · Infection and Immunity · doi:10.1128/iai.27.2.650-656.1980 · Cited by 113
Melgar, G. R., Nasser, R. M., Gordon, S. M., Lytle, B. W., Keys, T. F., & Longworth, D. L. (1997) · Medicine · doi:10.1097/00005792-199703000-00002 · Cited by 112
Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis
Muehrcke, D. D., Lytle, B. W., & Cosgrove, D. M. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00469-2 · Cited by 110 · cited 2×
“A small series of 12 patients, most of whom had Candida FE and none Aspergillus, had an overall survival rate of 67% [31].”
BackgroundSeelig, M. S., Speth, C. P., Kozinn, P. J., Taschdjian, C. L., Toni, E. F., & Goldberg, P. E. (1974) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(74)90027-9 · Cited by 94
Incidence and Risk of Developing Fungal Prosthetic Valve Endocarditis after Nosocomial Candidemia
Nasser, R. M., Melgar, G. R., Longworth, D. L., & Gordon, S. M. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)90050-4 · Cited by 89
Testing the Physician's Knowledge of Antibiotic Use: Self-Assessment and Learning Via Videotape
Neu, H. C., & Howrey, S. P. (1975) · New England Journal of Medicine · doi:10.1056/nejm197512182932505 · Cited by 70
Candida albicans Endocarditis: Ultrastructural Studies of Vegetation Formation
Calderone, R., Rotondo, M. F., & Sande, M. A. (1978) · Infection and Immunity · doi:10.1128/iai.20.1.279-289.1978 · Cited by 64
Changing patterns and prognosis of infective endocarditis in childhood
Normand, J., Bozio, A., Étienne, J., Sassolas, F., & Bris, H. L. (1995) · European Heart Journal · doi:10.1093/eurheartj/16.suppl_b.28 · Cited by 59
New perspectives in the diagnosis of systemic fungal infections
Richardson, M. D., & Kokki, M. H. (1999) · Annals of Medicine · doi:10.3109/07853899908995899 · Cited by 47
Experimental Candida albicans endocarditis: characterization of the disease and response to therapy
Sande, M. A., Bowman, C., & Calderone, R. (1977) · Infection and Immunity · doi:10.1128/iai.17.1.140-147.1977 · Cited by 47
Ellis, M. E. (1997) · Journal of Infection · doi:10.1016/s0163-4453(97)91347-5 · Cited by 46
Self-citationFungal endocarditis — a report on seven cases and a brief review
Hogevik, H., & Alestig, K. (1996) · Infection · doi:10.1007/bf01780644 · Cited by 43
Fungal endocarditis: patients at risk and their treatment
Seelig, M. S., Goldberg, P. K., Kozinn, P. J., & Berger, A. R. (1979) · Postgraduate Medical Journal · doi:10.1136/pgmj.55.647.632 · Cited by 36
Long-term survival after fluconazole therapy of candidal prosthetic valve endocarditis
Czerwiec, F. S., Bilsker, M., Kamerman, M. L., & Bisno, A. L. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90092-4 · Cited by 36
Fungal prosthetic valve endocarditis.
Muehrcke, D. D. (1995) · PubMed · Cited by 33
Amphotericin B preparations: a maximum tolerated dose in severe invasive fungal infections?
Ellis, M. E. (2000) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2000.020203.x · Cited by 33
Self-citationFungal endocarditis in critically ill children
Aspesberro, F. P., Beghetti, M., Oberh�nsli, I., & Friedli, B. (1999) · European Journal of Pediatrics · doi:10.1007/s004310051071 · Cited by 33
Fungal endocarditis in bone marrow transplantation: case report and review of literature
Chim, C. S., Ho, P., Yuen, S. T., & Yuen, K. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)92169-7 · Cited by 31
Experimental aspergillus endocarditis in rabbits.
Carrizosa, J., Kohn, C. W., & Me, L. (1975) · PubMed · Cited by 29
Seminars in Thoracic and Cardiovascular Surgery
(2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(13)01052-0 · Cited by 21
Endocarditis due to Aspergillus flavus
Khan, Z., Sanyal, S. C., Mokaddas, E. M., Vislocky, I., Anim, J. T., Salama, A. L., & Shuhaiber, H. J. (1997) · Mycoses · doi:10.1111/j.1439-0507.1997.tb00217.x · Cited by 18
Lejko-Zupanc, T., & Koželj, M. (1997) · Journal of Infection · doi:10.1016/s0163-4453(97)91145-2 · Cited by 18
r-Hirudin in unstable angina pectoris Rationale and preliminary data from the APT pilot study
Fox, K. A. A. (1995) · European Heart Journal · doi:10.1093/eurheartj/16.suppl_d.28 · Cited by 14
Research works printed but not linked: 2
- Rubinstein, 1975, Medicine, 54, 331
- 1958, Medicine, 48, 242
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Metadata
- Authors
- Ellis, M. E., Al-Abdely, H., Sandridge, A., Greer, W., & Ventura, W.
- Affiliations
- United Arab Emirates University (AE)
- King Faisal Specialist Hospital & Research Centre (SA)
- Corresponding author
- Ellis, M. E.
- ORCID
- Ellis, M. E.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-01-01
- Volume
- 32
- Issue
- 1
- Pages
- 50-62
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2103713801
- Cited by
- 505
- References
- 35
- Citations by year
- 2026: 6 · 2025: 21 · 2024: 11 · 2023: 16 · 2022: 12 · 2021: 17 · 2020: 23 · 2019: 19 · 2018: 23 · 2017: 19 · 2016: 21 · 2015: 35 · 2014: 29 · 2013: 34 · 2012: 17
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- fungal endocarditis, Candida albicans, non-albicans Candida, Aspergillus, Histoplasma, emerging fungal infections, risk factors, delayed diagnosis, mortality, survival, echocardiography, amphotericin B, recurrence, antifungal prophylaxis, immunocompromised patients
- MeSH terms
- Adolescent, Adult, Aged, Child, Child, Preschool, Endocarditis, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Mycoses, Risk Factors, Time Factors, Global Health, Survivors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.